Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025

Information Regarding the Total Number of Voting Rights and
Total Number of Shares of the Company as of October 31, 2025

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers )

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345




Date


Total number of shares Total number of voting rights
10/31/2025


179,827,919





Total gross of voting rights: 179,827,919





Total net* of voting rights: 179,741,847


* Net total = total number of voting rights attached to shares shares without voting rights

Attachment


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

DBV Technologies SADBVTNASDAQ:DBVTLife Science Investing
DBVT
The Conversation (0)
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest News

More News

Latest Press Releases

Significant Gold Discoveries Continue at Golden Gate - Drilling Hits 253.0m @ 1.5 g/t Au from Surface and Open in all Directions Ending in Mineralisation

Trading Halt

BTR strengthens leadership team to drive production growth

Detailed Ground Gravity, Magnetic and Radiometric Surveys Refine Priority REE Targets at Desert Star Projects, California, USA

Related News

gold investing

Significant Gold Discoveries Continue at Golden Gate - Drilling Hits 253.0m @ 1.5 g/t Au from Surface and Open in all Directions Ending in Mineralisation

Base Metals Investing

Trading Halt

Precious Metals Investing

BTR strengthens leadership team to drive production growth

rare earth investing

Detailed Ground Gravity, Magnetic and Radiometric Surveys Refine Priority REE Targets at Desert Star Projects, California, USA

Precious Metals Investing

CSAMT Findings - a Large-Scale Hydrothermal Antimony System

Nickel Investing

Top 5 Canadian Nickel Stocks of 2025

Critical Metals Investing

Australia and Canada Sign Joint Declaration of Intent on Critical Minerals